Phase 1 Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT05852587 Sponsor: Brigham and Women's Hospital Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 1 Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT05852587
Not Yet Recruiting Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have signed a consent form agreeing to take part in the study.
  • People who are male or female and aged 18 or older.
  • People who have been diagnosed with inflammatory bowel disease (IBD), including Crohn's disease, ulcerative colitis, or indeterminate colitis.
  • People whose IBD is currently inactive or only mildly active, based on specific disease activity scores (confirm with trial site).
  • People who are attending an outpatient colonoscopy or clinic appointment for any reason.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are unable to give their own consent to participate.
  • People who have previously had surgery to remove part or all of the colon, or who have a stoma bag, J-pouch, or any other previous colon surgery (except appendix removal).
  • People who are unable to complete the required study procedures.
  • People who regularly take antibiotics on an ongoing basis.
  • People who are unable or unwilling to swallow capsules.
  • People who have an allergy to xylitol (a sugar substitute).
  • People whose stool sample has tested positive for a bacteria called Listeria monocytogenes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026

Contact this trial

Principal Investigator: Jessica R Allegretti, MD, Brigham and Women's Hospital

Phone: 6175257322

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 January 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

C.difficile decolonization; safety and tolerability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov